Syngenta, a global leader in agricultural innovation, and Ascribe Bioscience announced the signing of a landmark development and supply agreement for PHYTALIX®, a new biofungicide that has been proven to significantly enhance crop resistance against fungal, bacterial, and viral diseases.
Under the terms of the agreement, Syngenta will have exclusive commercial access to PHYTALIX® for use in rice and other major crops in Southeast Asia with potential expansion in other regions.
This commercial partnership follows four years of validation by Syngenta through extensive trials, where PHYTALIX® delivered strong results thus making the product a valuable tool in integrated pest management (IPM) practices, as for instance against Bacterial Leaf Blight, while supporting consistent and significant yield gains in rice.
PHYTALIX®, based on discoveries made in the Boyce Thompson Institute at Cornell University, mimics plants’ natural processes and enables growers to empower crops like rice, soybeans, corn, and wheat with enhanced resistance to a wide range of pathogens throughout the growing season.
Also Read: Cropin Expands Global AgTech Analytics Through Sisense Partnership
This commercial agreement will bring rice farmers in the region a new sustainable option that bridges the gap between conventional solutions and biocontrols. Rice is a daily staple for nearly half of the world’s population, and demand is rising in the face of climate stress, emerging diseases, and resistances that challenge farmers’ ability to maintain yields.
PHYTALIX® offers high stability, low application rates, and a novel mode of action that controls a broad spectrum of pathogens making it suitable for adoption on farms of all sizes to control complex diseases like Bacterial Leaf Blight in rice.
“The collaboration with Ascribe reflects our commitment to bringing farmers differentiated solutions that help them implement more efficient farming strategies and more modern farming approaches by combined use of conventional and biological products,” said Emilhano Lima, Syngenta’s Global Head Seedcare and Biologicals. “Partnering with other innovators in the industry is crucial to accelerate the delivery of biological solutions to the farmers who need them most,” concluded Syngenta’s Lima.
Dr. Jay Farmer, cofounder and CEO of Ascribe, added: “By partnering with Syngenta in Asia, we’re able to bring this innovation out of the lab and into the hands of farmers who need new, sustainable options to manage crop diseases. Syngenta’s partnership represents strong validation of the global potential for PHYTALIX®.”
SOURCE: Businesswire
